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The prevalence of hypoechoic carotid plaques is
greater in peripheral than in coronary artery
disease and is related to the neutrophil count
Gregorio Brevetti, MD, Giusy Sirico, MD, Simona Lanero, MD, Julieta Isabel De Maio, MD,
Eugenio Laurenzano, MD, and Giuseppe Giugliano, MD, Naples, Italy
Objective: Previous reports indicate that the prevalence and severity of carotid stenoses is greater in peripheral artery
disease (PAD) than in coronary artery disease (CAD). To date, no study has compared these two populations with respect
to plaque echogenicity, which is an independent risk factor for cerebrovascular events.
Methods: In 43 PAD patients without CAD and in 43 CAD patients without PAD, carotid plaques were studied with
high-resolution B-mode ultrasound and by computerized measurement of the gray-scale median.
Results: At visual analysis, the prevalence of hypoechoic plaques was 39.5% in PAD and 18.6% in CAD (P  .033). The
corresponding values for gray-scale median analysis were 34.9% and 14.0% (P  .024). At multivariate analysis, PAD
patients showed a greater risk of having hypoechoic plaques than CAD patients at visual (odds ratio [OR], 4.39, 95%
confidence interval [CI] 1.21-15.92, P  .025) and gray-scale median analysis (OR, 5.13; 95% CI, 1.27-20.67; P 
.021). This association was no longer significant when neutrophil number was included among the covariates. In this
model, only an increased neutrophil count was associated with hypoechoic plaques (P < .01 for both visual and gray-scale
median analysis). Indeed, neutrophil count was greater in PAD than in CAD (4.4  1.0 vs 3.9  1.2 109/L, P  .030).
The concordance between visual typing of carotid plaques and gray-scale median measurement was good (  0.714,
P < .01).
Conclusions: Compared with CAD patients, those with PAD, in addition to a greater atherosclerotic burden, may have
characteristics of instability of carotid plaques that, in turn, may result in cerebrovascular events. Prospective studies are
needed to assess specifically whether the greater prevalence of hypoechoic plaques in PAD vs CAD patients is associated
with a greater risk of cerebrovascular events. ( J Vasc Surg 2008;47:523-9.)Atherosclerosis is a systemic disease and thus its local-
ization is often associated with vascular alterations in other
vascular districts. With respect to the coexistence of carotid
stenoses with other arterial diseases, it seems to be more
common and severe in peripheral arterial disease (PAD)
than in coronary artery disease (CAD).1-5 In particular, the
Second Manifestations of ARTerial (SMART) disease
study4 showed that the prevalence of carotid stenosis 70%
was 12.5% in PAD and only 3.1% in CAD. Similarly in
another series, carotid stenosis 70% was present in 24.5%
of PAD patients and in 11.1% of CAD patients.5 This may
partly explain the higher incidence of stroke in the former
group.
The Clopidogrel versus Aspirin in Patients at Risk of
Ischaemic Events (CAPRI) study showed that the occur-
rence of fatal and nonfatal stroke at follow-up in the PAD
subgroup was double that in the myocardial infarction
subgroup, in both the clopidogrel and aspirin arm.6 Fur-
thermore, and probably more indicative of the greater risk
of stroke in PAD are the results of the Reduction of
Atherothrombosis for Continued Health (REACH) Reg-
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doi:10.1016/j.jvs.2007.10.054istry, which reported a greater 1-year stroke incidence in
PAD patients with concomitant cerebrovascular disease
than in patients with CAD and cerebrovascular disease.7
However, many cerebrovascular events are associated
with carotid stenoses 75%, thus indicating that other
mechanisms are involved such as cardiac or aortic embo-
lism, lacunar infarction, valvular disease with atrial fibrilla-
tion, and embolism from carotid bifurcation. The latter
appears to be the most common pathogenetic mechanism
for cerebral ischemia.8,9 Indeed, plaque composition, as
reflected by its echogenicity, is an independent risk factor
for incident stroke.10-12 Plaques that appear with low echo-
genicity on B-mode ultrasound scanning have an increased
lipid content that renders them more prone to rupture,
whereas plaques with high echogenicity consist mainly of
fibrin and collagen, which makes them more stable.13,14
Although previous reports indicate that the prevalence of
significant carotid stenoses is greater in PAD than in CAD
subjects,1-5 to our knowledge, no study has compared these
two populations with respect to plaque echogenicity. Ac-
cordingly, we investigated this neglected area.
METHODS
The PAD group consisted of subjects referred to our
Angiology Section for intermittent claudication. Peripheral
arterial disease was diagnosed by an ankle-brachial index
(ABI) 0.90 associated with one or more stenoses of
50% in the arteries supplying the legs. Peripheral arterial
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excluded. Those without a CAD history underwent dipy-
ridamole myocardial perfusion imaging to verify the pres-
ence or absence of ischemic heart disease.
The CAD group consisted of patients with stable CAD
recruited at the Cardiology Section of our department. In
these subjects, the diagnosis of CAD was considered posi-
tive when confirmed with hospital records documenting
previous myocardial infarction, positive on a treadmill stress
test result, positive myocardial scintigram result, or positive
angiogram result. Coronary artery disease patients who had
sustained a myocardial infarction or who underwent a
coronary revascularization procedure in the previous 6
months were excluded. All CAD patients underwent vas-
cular examination, and the presence of PAD was excluded
by normal ABI and in the absence of peripheral artery
stenoses on duplex ultrasound scanning.
Because we focused on the echogenicity of plaques, the
inclusion criterion for this study was the presence of carotid
plaques at the bifurcation 1.3 mm in thickness, the
echolucency of which assessed by visual and computer-
assisted techniques, is highly reproducible.15 Patients with
smaller plaques were not included because such plaques
could not be clearly separated from diffused, thickened,
intima-media complex. B-mode ultrasound has been vali-
dated for the measurement of intima-media thickness in
several independent laboratories and its reliability is well
established.16,17 Other exclusion criteria were absence of
carotid plaques, calcified plaques with acoustic shadow
because it was technically impossible to determine their
echogenicity reliably, and carotid endarterectomy.
Each patient’s clinical history and risk factors were
assessed. “Smokers” were current smokers. Hypertension
was diagnosed if systolic arterial pressure was 140 mm Hg
or diastolic arterial pressure was 90 mm Hg, or both, or if
the patient used antihypertensive drugs. Hypercholesterol-
emia was diagnosed if plasma total cholesterol was 240
mg/dL, if plasma low-density lipoprotein cholesterol was
130 mg/dL, or if the patient used lipid-lowering drugs
because of a history of hypercholesterolemia. Diabetes mel-
litus was diagnosed if plasma fasting glucose was 126
mg/dL or if the patient used hypoglycemic agents. All
patients gave informed consent to the protocol, which was
approved by the Ethics Committee at our institution.
Both carotid bifurcations were examined by high-
resolution B-mode ultrasound. The B-mode and corre-
sponding color Doppler images were recorded onto super-
VHS videotape and digitized with PixelView, Hi Speed
USB 2.0 TV/Capture box (PROLINK Microsystems
Corp, Taipei, Taiwan). If plaque was found in both carotid
bifurcations, the one with greater echolucency was used for
the analysis.
Symptomatic patients who had experienced ischemic
stroke, transient ischemic attack, or amaurosis fugax on the
side related to the plaque with the greater echolucency were
included. Conversely, we excluded three patients with a
previous cerebrovascular event in the territory contralateral
to that of the plaque showing the greatest echolucencybecause their inclusion could have had a confounding effect
on the evaluation of the relationship between the gray-scale
median (GSM) analysis and symptomatic plaques.
The diagnosis of ischemic stroke was confirmed by a
computed tomography scan that showed ischemic infarc-
tion and ruled out cerebral hemorrhage. Patients with
bilateral hemispheric symptoms and those with known
cardiac mural thrombus (as verified on echocardiogra-
phy) were excluded from the analysis because of sus-
pected cardioembolic origin. Also excluded were pa-
tients with severe valvular disease and atrial fibrillation.
Carotid stenosis  50% was defined by systolic velocity
 130 cm/s.18 All examinations were done by the same
well-trained sonographer (S. L.), who was blinded to
patient clinical details.
After carotid examination, blood was drawn from an
antecubital vein using a 19-gauge needle in a Vacutainer
system (Becton-Dickson, Franklin Lakes, NJ). Neutrophil
count was then measured by the Bayer H*2 hematology
analyzer (Bayer Diagnostic Division, Tarrytown, NY).
Visual analysis. The recording was first evaluated by
visual analysis. All the images were transferred to a personal
computer, enlarged twofold, and then studied. The plaque
margins were delineated using the color images as a guide.
The plaques were classified according to a modified version
of the classification proposed by Gray-Weale et al19,20 and
graded as echolucent (type 1), predominantly echolucent
(type 2), predominantly echogenic (type 3), or echogenic
(type 4). To ensure uniformity and an unbiased approach in
the analysis, B-mode images were evaluated by the same
examiner (S. G.), who was unaware of the clinical profile of
the patients. Plaques were divided into two different types
for analysis: hypoechoic when their echolucency involved
50% of the plaque area (type 1 and type 2 plaques) and
echorich when the hyperechoic structure involved 50% of
the plaque area (type 3 and type 4 plaques).
Gray-scale median analysis. The overall brightness of
the carotid plaque was analyzed by a single investigator
(D. M. J.), who was unaware of the visual analysis. The
computer-assisted analysis used the software Image Pro-
cessing and Analysis in Java (Image J, National Institutes of
Health, Bethesda, Md) for standardization and echogenic-
ity analysis. Standardization was achieved as previously
reported.21 The GSM of the frequency distribution of gray
values of the pixels within the plaque was used as the
measurement of the echogenicity. After standardization,
the plaque was outlined and its overall brightness evaluated
by means of the median GSM range: 0 (black) to 255
(white). The median GSM value of the plaque was adjusted
linearly so that the median value of blood was 0 and that of
the adventitia was 190. To distinguish hypoechoic from
echorich plaque on the computer-assisted analysis, we used
the 25th percentile of GSM value of 34.9.
Statistical analysis. The relationship between the
plaque type (visual analysis) and the mean GSM was evalu-
ated by the Spearman analysis (). To assess the reproduc-
ibility, 30 plaques were re-evaluated by the same operator
ian; P
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Intraoperator agreement was assessed by  statistics. Group
comparisons were made by 2 test, and the t test for
unpaired samples, as appropriate. For both the visual and
GSM method, multivariate regression analysis was used to
identify the independent association of clinical variables
with the presence of hypoechoic carotid plaques. Both
analyses were initially adjusted for age, sex, and presence of
PAD (model 1). We then included, as covariates, risk
factors showing group difference (inclusion criteria
P  .1)22 at the univariate analysis (model 2). In a third
model, the neutrophil count exceeding the median was
added to the other covariates. Data are presented as
mean  SD, unless indicated otherwise.
RESULTS
We screened 128 consecutive PAD and 86 consecutive
CAD patients. Absence of carotid plaque was observed in
three PAD and in seven CAD patients. As required by the
study protocol, 75 PAD patients with coexistent CAD and
19 CAD patients with coexistent PAD were excluded. Also
excluded were 4 PAD and 7 CAD subjects with calcified
plaques, and 1 PAD and 1 CAD subject who underwent a
previous endarterectomy, 1 CAD patient with mitral steno-
sis and atrial fibrillation, and 7 CAD subjects with previous
myocardial infarction or who had undergone coronary
revascularization in the previous 6 months. Finally, two
PAD patients and one CAD patient were excluded because
of a previous cerebral event in the territory of the plaque
contralateral to that showing the greater echolucency. After
exclusion of these patients, the study sample comprised 43
PAD and 43 CAD patients. The principal characteristics of
the study population are listed in Table I). Notably, the
number of symptomatic plaques was 16 in the PAD group
(37.2%) and seven in the CAD group (16.3%; P  .028),
and the two groups had a similar prevalence of carotid
artery stenoses 50%.
With respect to the relationship between hypoechoge-
nicity and symptomatic plaques, multivariate analysis
showed that hypoechoic carotid plaques (GSM 34.9)
were significantly associated with previous cerebrovascular
Table I. Characteristics of the study population
Variable CAD (n 
Age, mean  SD y 64.9  1
Males, No. (%) 35 (81.4
Hypercholesterolemia, No. (%) 34 (79.1
Diabetes, No. (%) 15 (34.9
Hypertension, No. (%) 39 (90.7
Active smoking, No. (%) 10 (23.3
BMI mean  SD kg/m2 27.8  3
Symptomatic plaques, No. (%) 7 (16.3
Carotid stenosis 50%, No. (%) 8 (18.6
Hypoechoic plaques, No. (%)
At visual analysis 8 (18.6
At GSM analysis (%) 6 (14.0
BMI, body mass index; CAD, coronary artery disease; GSM, gray-scale medevents and also when adjusted for severity of stenosis (oddsratio [OR], 3.61; 95% confidence interval [CI], 1.05-
12.65; P  .048).
The prevalence of hypoechoic plaques was markedly
higher in the PAD group than in the CAD group both at
visual analysis (39.5% vs 18.6%, P  .033) and at GSM
analysis (34.9% vs 14.0%, P .024) when the 25th percen-
tile of the GSM was used as cutoff. Furthermore, the GSM
score was significantly lower in PAD than in CAD patients
(53.6  32.6 vs 67.1  25.4, P  .035). These observa-
tions are supported by the finding that the GSM results are
in agreement with the echogenicity as established visually:
the lowest GSM score (9.6  7.8) corresponded to type 1
plaques, and the highest GSM score (81.3  17.5) corre-
sponded to type 4 plaques. Plaques of type 2 and 3 pre-
sented intermediate values (39.6 28.03 and 69.2 17.7,
respectively). As reported in Fig 1, Spearman analysis
showed that plaque type and mean GSM values were sig-
nificantly correlated (  0.714, P  .01).
Multivariate analysis (Table II, model 2) showed that
after adjustment for potential confounders, PAD patients
had a 4.4-fold increased risk of having carotid plaques of
type 1 or 2 (hypoechoic) compared with CAD subjects.
PAD (n  43) P
64.9  9.5 .99
31 (72.1) .307
35 (81.4) .776
10 (23.3) .263
27 (62.8) .003
26 (60.5) .001
26.6  2.3 .077
16 (37.2) .028
8 (18.6) .99
17 (39.5) .033
15 (34.9) .024
AD, peripheral arterial disease.
Fig 1. Correlation between visual classification of plaque echoge-
nicity (four types) and mean gray-scale median values (GSM)
presented with the standard deviation (whiskers). Spearman analy-
sis   0.714; P  .01.43)
0.9
)
)
)
)
)
.6
)
)
)
)Also, age was independently associated with the presence of
..
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with hypoechoic plaques were younger than those with
echorich plaques (61.1  10.1 vs 66.5  9.9 yr, P 
0.024).
Results of the GSM analysis confirmed the results ob-
tained by visual analysis. The presence of PAD and younger
age were independently associated with a GSM 34.9,
indicating lower plaque echogenicity (Table III, model 2).
We found a significant inverse relationship between the
four plaque types and the neutrophil count (  0.411,
P .01). The echogenicity measured by GSM analysis also
correlated negatively with the number of neutrophils ( 
0.423, P  .01). The number of neutrophils was higher
in type 1 and 2 plaques (considered collectively) than in the
subgroup comprising type 3 and 4 plaques (4.9  1.0 vs
3.8  1.1	 109/L, P  .01; Fig 2). Similarly, when the
25th percentile of the GSM median value was used to
divide plaques into two groups, the neutrophil count was
4.9 1.0	 109/L in hypoechoic and 3.9 1.0	 109/L
(P  .01) in echorich plaques (Fig 2). Fig 2 similarly shows
that hypoechoic plaques were much more common in the
group of patients with neutrophil numbers exceeding the
Table II. Predictors of hypoechoic carotid plaques evalua
Model 1
OR 95% CI P OR 95% C
PAD 2.86 1.07-7.63 .036 3.64 1.26-10.
Age 0.94 0.90-0.9
Male sex 3.33 0.80-13.
Hypertension
Active smoking
Body mass index
Neutrophil count
median
CI, Confidence interval; OR, odds ratio; PAD, peripheral arterial disease.
aAnalyses adjusted for age, sex, and presence of PAD.
bAnalysis includes risk factors showing group difference (inclusion criteria P
cNeutrophil count exceeding the median was added to the other covariates
Table III. Predictors of hypoechoic carotid plaques (gray
analyses
Model 1
OR 95% CI P OR 95% CI
PAD 3.30 1.14-9.60 .028 4.37 1.38-13.8
Age 0.94 0.89-1.00
Male sex 4.52 0.87-23.5
Hypertension
Active smoking
Body mass index
Neutrophil count
median
CI, Confidence interval; OR, odds ratio; PAD, peripheral arterial disease.
aAnalyses adjusted for age, sex, and presence of PAD.
bAnalysis includes risk factors showing group difference (inclusion criteria P
cNeutrophil count exceeding the median was added to the other covariatesmedian (3.8	 109/L) than in those with lower neutrophillevels (48.8% vs 9.3%, P  .01, for visual analysis; 41.9% vs
7.0%, P  .01, for GSM analysis). Notably, the increased
risk associated with PAD of having hypoechoic plaques was
no longer significant when the neutrophil number exceed-
ing the median was added to the multivariate analyses
(Tables II and III, model 3). In this model, only an
increased neutrophil count was independently associated
with the presence of hypoechoic plaques (Table II and III,
model 3). It is noteworthy that these findings did not
change when the neutrophil count was included in the
model as a continuous variable (results not shown). Indeed,
PAD patients showed a greater number of neutrophils than
patients with CAD (4.4  1.0 vs 3.9  1.2 	 109/L,
P  .03).
Overall, 53 patients (61.6%) were taking statins (29 in
the CAD and 24 in the PAD group). Statistical analysis did
not show any difference in plaque echogenicity related to
the use of statins, GSM being 60.2 28.9 in patients with
statin use and 59.6  31.4 in those without.
The agreement between two repeated evaluations of
the plaques was excellent for both visual analysis ( 0.83)
y visual analysis at univariate and multivariate analyses
Model 2b Model 3c
P OR 95% CI P OR 95% CI P
.017 4.39 1.21-15.92 .025 2.83 0.72-11.05 .135
.031 0.94 0.89-0.99 .047 0.95 0.89-1.01 .098
.098 3.83 0.80-18.35 .093 4.11 0.70-24.25 .118
0.76 0.21-2.70 .671 0.82 0.21-3.16 .769
1.48 0.41-5.29 .549 1.53 0.37-6.41 .557
1.14 0.93-1.41 .209 1.13 0.90-1.41 .298
9.34 2.30-37.96 .002
) at the univariate analysis as covariates.
median score  34.9) at univariate and multivariate
Model 2b Model 3c
P OR 95% CI P OR 95% CI P
.012 5.13 1.27-20.67 .021 3.39 0.81-14.14 .094
.042 0.94 0.88-0.99 .047 0.94 0.88-1.01 .090
.073 4.43 0.75-26.15 .101 4.45 0.61-32.41 .140
0.74 0.20-2.82 .659 0.76 0.19-3.09 .701
1.26 0.33-4.86 .733 1.26 0.28-5.63 .762
1.07 0.85-1.33 .577 1.03 0.81-1.30 .831
10.83 2.09-56.03 .005
) at the univariate analysis as covariates.ted b
a
I
53
9
83
 .1-scale
a
8
1
 .1and GSM analysis (  0.87).
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The results of this study suggest that hypoechoic
plaques are much more common in patients with PAD than
in patients with chronic stable CAD. Actually, at visual
analysis, the number of PAD patients with hypoechoic
plaques was double that observed in the CAD group. The
prevalence of carotid plaques with a very low GSM score
(34.9) was also markedly higher in PAD than in CAD.
These findings may have clinical relevance because type 1
and 2 carotid plaques11 and plaques with a GSM value 32
or 40 have been reported to be closely associated with
cardiovascular events.23,24 Of interest in our series is that
Fig 2. Number of neutrophils in coronary artery disease and
peripheral arterial disease patients evaluated by visual analysis (up-
per panel) and gray-scale median (GSM) analysis (lower panel).
With both procedures, the neutrophil count was higher in patients
with hypoechoic than in those with echorich plaques. Further-
more, the prevalence of hypoechoic plaques in patients with a
neutrophil number that exceeded the median was markedly higher
than in those with a neutrophil number that was less than the
median. Type 1 and type 2 plaques were considered hypoechoic for
the visual analysis; whereas plaques with a GSM value of34.9 (ie,
the 25th percentile of the GSM median value) were considered
“hypoechoic” for the GSM analysis. Data are presented with the
standard deviation (error bars).the number of symptomatic plaques was significantlygreater in PAD patients than in CAD patients. We consid-
ered plaque as a tract of the carotid where the intima-media
thickness was 1.3 mm, which is the limit suggested by the
Prevention Conference V25 and used in most studies on
plaque echogenicity.26-28 However, the extent to which
carotid intima-media thickness is a manifestation of early or
diffuse atherosclerosis, as opposed to smooth-muscle hy-
pertrophy or hyperplasia, or both, is uncertain.29
The higher prevalence of hypoechoic carotid plaques in
PAD may not be attributed to group differences in classic
risk factors, which were not significantly associated with
this plaque type at the multivariate analyses. Therefore,
other mechanisms are likely to be involved in determining
plaque hypoechogenicity.
Inflammation has a key role in every aspect of the
atherosclerotic process, and recent investigations report
that the presence of high-risk carotid plaques is associated
with increased levels of inflammatory markers, such as
C-reactive protein, leukocyte count, and fibrinogen.30-32
In our study, we found a significant inverse relationship
between plaque echogenicity and the neutrophil count.
Patients with hypoechoic plaques therefore had a signifi-
cantly higher number of neutrophils than those with
echorich plaques, independently of age, sex, and classic risk
factors. Notably, at the multivariate analyses, when neutro-
phil count exceeding the median was added to the other
covariates, the association between PAD and hypoechoic
plaques was no longer significant. Indeed, PAD patients
showed a higher number of neutrophils than those with
CAD. Therefore, the finding that the prevalence of hypo-
echoic plaques was higher in PAD than in CAD patients
was probably because, consistent with previous stud-
ies,33,34 the PAD group had a more pronounced inflamma-
tory profile. Because administration of statins is reported to
have a stabilizing effect on carotid plaques,35 we compared
plaque echogenicity in patients who were on statin treat-
ment with that in patients not taking statins. No group
differences were observed. We were unaware of the dura-
tion of statin treatment in each patient however; therefore,
we cannot exclude that some patients had only recently
started taking statins.
Another important result of our study is that, as already
reported,36,37 there was a good concordance between vi-
sual typing of carotid plaques and GSM measurement.
Types of carotid plaques and GSM scores were linearly
correlated, with a low GSM corresponding to echolucent
(type 1) carotid plaques and a highGSM to echogenic (type
4) carotid plaques. It is therefore questionable whether the
GSM method, although accurate and objective, should be
preferred to the visual analysis, considering that it requires
additional equipment and is time-consuming.
Study limitation. A limitation of our study is that the
results were obtained in a relatively small cohort. However,
the differences between the CAD and PAD groups were so
marked that they argue convincingly in favor of a higher
prevalence of hypoechoic plaques in PAD patients. A sec-
ond limitation is that we used the 25th percentile of the
median GSM value as an arbitrary end point to distinguish
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knowledge, however, no GSM cutoff has been established
to identify hypoechoic plaques and thus far, various cutoff
values have been used.23,24,38,39 We used the 25th percen-
tile of the median GSM because this value was low enough
to identify hypoechoic plaques in a number of patients
sufficiently high for statistical analysis purposes. In this
context, it is noteworthy that the prevalence of hypoechoic
plaques measured with the two techniques was very similar
in the two groups of patients. Furthermore, the value we
found of 34.9 is very similar to those used by others to
identify hypoechoic plaques.23,24,38,39
CONCLUSIONS
Our findings suggest that compared with CAD pa-
tients, those with PAD, probably as a consequence of a
greater inflammatory status, may have not only a greater
carotid atherosclerotic burden1-5 but also morphologic
characteristics associated with instability of carotid artery
plaques, which in turn might result in cerebrovascular
ischemic events.10-12 However, prospective studies are
needed to assess specifically whether the greater prevalence
of hypoechoic plaques in PAD vs CAD patients is associated
with a greater risk of cerebrovascular events.
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